Monte Rosa Therapeutics Inc (GLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 125,575 | 108,847 | 99,752 | 128,101 | 59,055 |
| Marketable Securities | 116,611 | 153,358 | 93,140 | 104,312 | 119,422 |
| Receivables | 595 | 9,842 | 601 | 505 | 294 |
| TOTAL | $251,207 | $277,896 | $199,036 | $236,212 | $182,911 |
| Non-Current Assets | |||||
| PPE Net | 31,442 | 33,250 | 34,036 | 33,803 | 34,992 |
| Other Non-Current Assets | 32,431 | 32,968 | 33,674 | 33,740 | 34,200 |
| TOTAL | $63,873 | $66,218 | $67,710 | $67,543 | $69,192 |
| Total Assets | $315,080 | $344,114 | $266,746 | $303,755 | $252,103 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,978 | 6,473 | 6,828 | 11,152 | 5,500 |
| Accrued Expenses | 15,099 | 12,759 | 10,713 | 14,600 | 14,228 |
| TOTAL | $41,641 | $42,348 | $41,293 | $46,592 | $22,609 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 18,918 | 19,645 | 20,407 | 17,678 | N/A |
| Other Non-Current Liabilities | 40,052 | 40,885 | 41,837 | 42,877 | 43,517 |
| TOTAL | $67,982 | $77,095 | $72,934 | $77,913 | $44,970 |
| Total Liabilities | $109,623 | $119,443 | $114,227 | $124,505 | $67,579 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 61,437 | 61,373 | 50,512 | 50,154 | 50,081 |
| Common Shares | 6 | 6 | 5 | 5 | 5 |
| Retained earnings | -452,025 | -428,166 | -397,856 | -365,888 | -332,636 |
| Other shareholders' equity | -2,322 | -2,670 | -2,693 | -2,724 | -1,455 |
| TOTAL | $205,457 | $224,671 | $152,519 | $179,250 | $184,524 |
| Total Liabilities And Equity | $315,080 | $344,114 | $266,746 | $303,755 | $252,103 |